Download PDF Flyer
Impact Factor Current: 2.530
5 - Year: 2.291

Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1573-4064
ISSN (Online): 1875-6638

Latest Issue: Volume 15 , Issue 7 , 2019

Back Journal Home
Impact Factor
Web of Science Impact Factor

Current: 2.530
5 - Year: 2.291

Ranking & Category

  • 30th of 59 in Chemistry, Medicinal

Topics Covered

1 Topics

View
Covered Diseases

0 Diseases

View

Aims & Scope

Medicinal Chemistry a peer-reviewed journal, aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design. The journal publishes original research, full-length/mini-review articles and guest edited thematic issues covering recent research and developments in the field. Articles are published rapidly by taking full advantage of Internet technology for both the submission and peer review of manuscripts. Medicinal Chemistry is an essential journal for all involved in drug design and discovery.

Abstracted/Indexed in


Science Citation Index Expanded (SciSearch®), Journal Citation Reports/Science Edition, InCites, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, MEDLINE/PubMed/Index Medicus, Scopus, EMBASE, Chemical Abstracts Service/SciFinder, ProQuest, ChemWeb, Google Scholar, Genamics JournalSeek, Media Finder®-Standard Periodical Directory, PubsHub, Index Copernicus, J-Gate, CNKI Scholar, Suweco CZ, TOC Premier, EBSCO, British Library, Ulrich's Periodicals Directory and JournalTOCs.

Announcements
Endorsement(s)
"Medicinal Chemistry is an invaluable journal, which contains the latest outstanding developments in medicinal chemistry. It is recommended to all scientists working in this field."

Michael Kassiou
University of Sydney, Australia
Authors' Comments

Thank you for your mail. I am very delighted to be the author of this article in your esteemed journal (Medicinal Chemistry, Bentham science publishers ). Glad to say that the quality of your service is very nice. I will surely contribute new research publication to this esteemed journal soon.


Sreekanth Thota  
(National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil.)

Has contributed: Drug Design, Synthesis and in vitro Evaluation of Substituted Benzofurans as Hsp90 Inhibitors.
© 2020 Bentham Science Publishers